Immune Cell Dynamics in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) arises against a backdrop of chronic inflammation in which innate and adaptive immune cells continually shape tumour progression. Cytotoxic CD8+ T lymphocytes and helper CD4+ T cells infiltrate malignant nodules to mediate tumour cell killing, while regulatory T cells (Tregs) and tumour‐associated macrophages establish an immunosuppressive niche that favours immune evasion. B cells, natural killer cells and neutrophils contribute further complexity through antibody production, direct cytotoxicity and modulation of inflammation. Spatial heterogeneity is apparent: immune cell densities at the tumour–stroma interface and within perineoplastic parenchyma bear distinct prognostic implications. Chronic hepatitis virus infection and metabolic stress drive T‐cell exhaustion, marked by inhibitory receptor up‐regulation and diminished effector function. Advances in single‐cell sequencing, spatial transcriptomics and computational deconvolution have elucidated novel subsets—such as cholinergic T cells—and unveiled dynamic crosstalk pathways that dictate immune surveillance, tolerance and response to immunotherapy.

Research from Nature Portfolio

Recent studies have unveiled an unanticipated role for cholinergic CD4+ T cells in constraining HCC development. In murine multihit models, two distinct populations of T cells expressing choline acetyltransferase expand within tumours, modulating Ca2+–NFAT signalling to fine‐tune regulatory and PD-1+ subsets. Genetic ablation of ChAT in T cells precipitates preneoplastic foci and exacerbates tumour growth by compromising antitumour immunity.

Foundational in silico analyses of high‐dimensional sequencing data have delivered the first global map of the HCC immune contexture. Robust infiltration by cytotoxic T cells and T helper 1–polarised lymphocytes correlates with improved survival, whereas elevated macrophage and Th2 signatures predict poorer outcome. These insights have underpinned a prognostic scoring system that stratifies patients according to the balance of effector and suppressive cell types.

A systematic review and meta‐analysis of tumour‐infiltrating lymphocytes further established that high densities of CD8+ and CD3+ cells associate with superior overall and recurrence‐free survival, while increased FoxP3+ Treg frequencies portend worse prognosis. Ratios of regulatory to effector subsets emerged as critical determinants of clinical outcome.

Immune Cell Dynamics in Hepatocellular Carcinoma publication trend

The graph below shows the total number of articles in immune cell dynamics in hepatocellular carcinoma across all publications each year (not limited to Nature Index journals).

Technical terms

Tumour-infiltrating lymphocytes (TILs): Immune cells, predominantly T cells, that have migrated into the tumour microenvironment and influence tumour control or progression.

Regulatory T cells (Tregs): A subset of CD4+ T cells that suppress effector immune responses, often fostering tumour immune evasion.

Programmed cell death protein 1 (PD-1): An inhibitory receptor on T cells whose engagement attenuates cytotoxic function and contributes to exhaustion.

Cholinergic T cells: T lymphocytes expressing choline acetyltransferase, capable of synthesising acetylcholine to modulate immune signalling.

Immune exhaustion: A dysfunctional state of chronic antigen‐exposed lymphocytes, characterised by sustained inhibitory receptor expression and impaired effector activity.

CIBERSORT: A computational method for deconvoluting gene expression data to estimate the relative proportions of immune cell subtypes in tissues.

References

1. Tumor-specific cholinergic CD4+ T lymphocytes guide immunosurveillance of hepatocellular carcinoma. Nature Cancer (2023).
2. The immune contexture of hepatocellular carcinoma predicts clinical outcome. Scientific Reports (2018).
3. The Prognostic Value of Tumor-infiltrating Lymphocytes in Hepatocellular Carcinoma: a Systematic Review and Meta-analysis. Scientific Reports (2017).
4. Peripheral immune characteristics of hepatitis B virus-related hepatocellular carcinoma. Frontiers in Immunology (2023).
5. Adhesion G Protein-Coupled Receptor G2 Promotes Hepatocellular Carcinoma Progression and Serves as a Neutrophil-Related Prognostic Biomarker. International Journal of Molecular Sciences (2023).
6. Prognostic Value of CD8+ Lymphocytes in Hepatocellular Carcinoma and Perineoplastic Parenchyma Assessed by Interface Density Profiles in Liver Resection Samples. Cancers (2023).